Fat chance for hypertension and chronic kidney disease

Hypertension

Volumn 58, Issue 5, 2011, Pages 756-757

  Hamm, L Lee ^a   Chen, Jing ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; LEPTIN; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ABDOMINAL FAT; ABDOMINAL OBESITY; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DYSLIPIDEMIA; EDITORIAL; ENDOTHELIAL DYSFUNCTION; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KIDNEY BLOOD FLOW; KIDNEY FAILURE; METABOLIC SYNDROME X; MICROALBUMINURIA; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM ABSORPTION; SUBCUTANEOUS FAT; SYMPATHETIC FUNCTION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; INTRA-ABDOMINAL FAT; MALE; RENAL INSUFFICIENCY, CHRONIC;

EID: 83155181555     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.180414     Document Type: Editorial

References (10)

1. Foster MC, Hwang S-J, Porter SA, Massaro JM, Hoffman U, Fox CS. Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension. 2011;58:784-790.
2. Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, Smith G, Stec DE. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285: 17271-17276.
3. Reisin E, Jack AV. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am. 2009;93: 733-751.
4. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2595-2600. (Pubitemid 38766337)
5. Okauchi Y, Nishizawa H, Funahashi T, Ogawa T, Noguchi M, Ryo M, Kihara S, Iwahashi H, Yamagata K, Nakamura T, Shimomura I, Mat-suzawa Y. Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men. Diabetes Care. 2007; 30:2392-2394. (Pubitemid 47359051)
6. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004;140:167-174.
7. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21-28. (Pubitemid 46780716)
8. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol. 2007;2:550-562.
9. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 201;305:1553-1559.
10. Vupputuri S, Fox CS, Coresh J, Woodward M, Muntner P. Differential estimation of CKD using creatinine-versus cystatin C-based estimating equations by category of body mass index. Am J Kidney Dis. 2009;53: 993-1001.